运动保护产品
Search documents
涉嫌内幕交易!603880 董事长及财务总监“栽了”
Zhong Guo Ji Jin Bao· 2025-11-04 14:56
【导读】因内幕交易,南卫股份董事长及前任财务总监被处罚 罚单落地!南卫股份董事长及前任财务总监因内幕交易,合计遭罚没超4870万元。 因涉嫌内幕交易 南卫股份董事长及前任财务总监被处罚 11月4日,南卫股份发布公告称,公司实际控制人及董事长李平、前任财务总监项琴华因涉嫌内幕交易,收到中国证监会江苏监管局《行政处 罚决定书》。 经查明,李平作为内幕信息知情人,在内幕信息敏感期内控制其股票账户卖出"南卫股份"818.40万股,成交金额为4796.78万元,避损1177.67万 元。 项琴华作为内幕信息知情人,在内幕信息敏感期内控制其股票账户卖出"南卫股份"5.4万股,成交金额为34.05万元,避损10.17万元。 | 南号 | 股东名称 | 持股数量(股) | 占总股本比例(%) | 期末参考市值(亿元) | | --- | --- | --- | --- | --- | | 1 | 李平 一致行动人(1) 实控人 童监高 | 118,841,048 | 41.12 | 7.30 | | 2 | 徐东 | 12,941,000 | 4.48 | 0.79 | | 3 | 李永平 一致行动人(1) | 9,639, ...
涉嫌内幕交易!603880,董事长及财务总监“栽了”
中国基金报· 2025-11-04 14:19
【导读】因内幕交易,南卫股份董事长及前任财务总监被处罚 中国基金报记者 李智 罚单落地! 南卫股份董事长及前任财务总监因内幕交易,合计遭罚没超 4870 万元。 因涉嫌内幕交易 南卫股份董事长及前任财务总监被处罚 11 月 4 日,南卫股份发布公告称,公司实际控制人及董事长李平、前任财务总监项琴华因涉 嫌内幕交易,收到中国证监会江苏监管局《行政处罚决定书》。 经查明,李平作为内幕信息知情人,在内幕信息敏感期内控制其股票账户卖出 " 南卫股份 "818.40 万股,成交金额为 4796.78 万元,避损 1177.67 万元。 项琴华作为内幕信息知情人,在内幕信息敏感期内控制其股票账户卖出 " 南卫股份 "5.4 万 股,成交金额为 34.05 万元,避损 10.17 万元。 根据相关规定,江苏监管局决定对李平没收违法所得 1177.67 万元,并处以罚款 3533 万 元;对项琴华没收违法所得 10.17 万元,并处以罚款 150 万元。 南卫股份表示,上述《行政处罚决定书》所述中国证监会江苏监管局作出的行政处罚不涉及 公司,且不涉及《上海证券交易所股票上市规则》规定的重大违法类强制退市情形,不会对 公司的日 ...
南卫股份的前世今生:2025年Q3营收4.47亿低于行业均值,净利润亏损行业排名靠后
Xin Lang Cai Jing· 2025-10-30 16:09
Core Viewpoint - Nanwei Co., Ltd. is a well-known enterprise in the medical dressing industry in China, focusing on the research, production, and sales of medical dressing products, with its product quality and technology ranking among the top in the industry [1] Group 1: Business Performance - For Q3 2025, Nanwei's revenue was 447 million yuan, ranking 33rd out of 50 in the industry, significantly lower than the top competitor, Yingke Medical, which reported 7.425 billion yuan [2] - The main business revenue breakdown includes 121 million yuan from adhesive bandages, accounting for 39.59%, and 86.05 million yuan from protective products, accounting for 28.11% [2] - The net profit for the same period was -24.84 million yuan, ranking 47th out of 50, far below the industry average of 183 million yuan [2] Group 2: Financial Ratios - As of Q3 2025, Nanwei's debt-to-asset ratio was 73.87%, an increase from 63.01% in the previous year, significantly higher than the industry average of 23.66% [3] - The gross profit margin for Q3 2025 was 10.68%, down from 12.41% in the previous year and well below the industry average of 48.78% [3] Group 3: Executive Compensation - The chairman and general manager, Li Ping, received a salary of 602,100 yuan in 2024, a slight increase from 600,800 yuan in 2023 [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 16.70% to 12,000, while the average number of circulating A-shares held per account increased by 20.05% to 24,000 [5]
涉嫌内幕交易!这一A股董事长、财务总监被罚
Zhong Guo Ji Jin Bao· 2025-08-08 01:44
Core Viewpoint - The chairman and CFO of Nanwei Co., Ltd. have been penalized for insider trading, with fines totaling nearly 50 million yuan due to their illegal stock transactions during a sensitive period of undisclosed information [2][4]. Group 1: Insider Trading Penalties - Nanwei Co., Ltd. announced that its controlling shareholder and chairman, Li Ping, along with CFO Xiang Qinhua, were fined and had their illegal gains confiscated, amounting to approximately 50 million yuan [2][4]. - The China Securities Regulatory Commission (CSRC) found that Li Ping and Xiang Qinhua engaged in insider trading during the sensitive period from March 1 to April 28, 2023, after being aware of significant negative information regarding the company's financial status [4][5]. - Li Ping sold 8.184 million shares of Nanwei Co., Ltd. for 47.9678 million yuan between March 14 and March 28, 2023, resulting in a profit of 11.7767 million yuan after taxes [5]. Group 2: Financial Performance and Forecast - Nanwei Co., Ltd. is expected to report a net loss of 12 million to 16 million yuan for the first half of 2025, attributed to rising raw material costs and constraints on product orders due to international trade policies and geopolitical factors [6][9]. - The company primarily engages in the research, production, and sales of transdermal products, medical adhesive tapes, bandages, and emergency care products [7]. - As of the end of the first quarter, Li Ping held 119 million shares, representing a 41.12% ownership stake in the company [7].
涉嫌内幕交易!这一A股董事长、财务总监被罚
中国基金报· 2025-08-08 01:30
Core Viewpoint - The chairman and CFO of Nanwei Co., Ltd. have been penalized for insider trading, with fines totaling nearly 50 million yuan due to their actions during a sensitive period of insider information [2][4][6]. Group 1: Insider Trading Incident - On August 7, Nanwei Co., Ltd. announced that its controlling shareholder and chairman, Li Ping, along with CFO Xiang Qinhua, received an administrative penalty notice from the Jiangsu Regulatory Bureau of the China Securities Regulatory Commission [4]. - The investigation revealed that Li Ping and Xiang Qinhua engaged in insider trading during the sensitive period from March 1 to April 28, 2023, selling a total of 818.4 million shares for approximately 47.97 million yuan, resulting in a profit of about 11.78 million yuan after taxes [5][6]. - The regulatory authority has proposed to confiscate illegal gains and impose fines: Li Ping faces a confiscation of 11.78 million yuan and a fine of 35.33 million yuan, while Xiang Qinhua faces a confiscation of 101,700 yuan and a fine of 150,000 yuan [6]. Group 2: Company Financial Performance - Nanwei Co., Ltd. is expected to report a net loss of 12 to 16 million yuan for the first half of 2025, attributed to rising raw material costs and constraints on product orders due to international trade policies and geopolitical factors [11]. - As of August 7, the company's stock price was 6.81 yuan per share, with a total market capitalization of 2 billion yuan [11]. Group 3: Company Overview - Nanwei Co., Ltd. specializes in the research, production, and sales of transdermal products, medical adhesive tapes, bandages, sports protection products, first aid kits, and nursing products, with key products including adhesive bandages and topical agents [8].